McKesson forward PE MCK

Share price divided by analysts' consensus earnings for the next twelve months, since 1997.

Today, Oct 23, 2026: 21.6×
10-year median: 13.3×
Against its 10-year history: 99th; percentile: 0 is its lowest day, 100 its highest
10-year range: 8.1× to 23.1×
Peer median: 16.0×

McKesson's forward PE is 21.6× as of Oct 23, 2026.

That is above its ten-year median of 13.3×, higher than on 99% of days in the last ten years.

Over that time it ranged from 8.1× in Mar 2019 to 23.1× in Feb 2026.

The median for 10 healthcare stocks of a similar size is 16.0×.

Forward PE over time

median 13.3×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	21.6×	16.6×	23.1×
2025	20.2×	16.4×	21.5×
2024	16.5×	14.8×	19.8×
2023	16.8×	12.8×	17.3×
2022	14.7×	10.8×	15.5×
2021	10.9×	8.8×	10.9×
2020	9.7×	8.5×	11.8×
2019	10.1×	8.1×	11.2×
2018	8.3×	8.2×	14.8×
2017	13.1×	11.4×	14.4×
2016	12.9×	11.4×	16.9×
2015	16.0×	14.5×	21.3×
2014	20.6×	17.2×	20.8×
2013	17.3×	12.8×	17.8×
2012	12.7×	11.6×	13.4×
2011	12.1×	11.9×	16.5×
2010	14.7×	12.9×	15.3×
2009	13.7×	8.3×	14.1×
2008	9.9×	8.1×	19.8×
2007	19.2×	17.1×	22.6×

Against its peers

Companies in Healthcare nearest McKesson's size, closest first, today.

Company	Forward PE
MCKMcKesson	21.6×
SYKStryker	19.3×
CVSCVS Health	11.5×
MDTMedtronic	15.9×
BMYBristol-Myers Squibb	10.4×
VRTXVertex Pharmaceuticals	27.0×
HCAHCA Healthcare	15.3×
ELVElevance Health	16.1×
ISRGIntuitive Surgical	37.5×
DHRDanaher	25.4×
REGNRegeneron Pharmaceuticals	12.6×
Peer median	16.0×

Where McKesson ranks

#31of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on McKesson

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.